Analytical Data
-
基因名
ATF7IP2
- Application
-
别名
ATF7-interacting protein 2;MBD1-containing chromatin-associated factor 2
-
种属
Human
-
表达系统
E. coli
-
标签
N- His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q5U623
-
表达区间
1–682aa
-
分子量
81.7 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ATF7IP2, a member of the ATF/CREB family of transcription factors, has garnered significant interest in recent years due to its potential roles in various cellular processes, including metabolism, stress response, and neurodevelopment. This protein is known to interact with other key factors in the regulatory network, influencing gene expression and cellular signaling pathways. Understanding the structure and function of ATF7IP2 is crucial, as its dysregulation has been implicated in several diseases, such as cancer and neurological disorders. Researchers have focused on the recombinant expression of ATF7IP2 to study its biochemical properties, functional domains, and interaction partners. The development of recombinant ATF7IP2 provides a platform for elucidating its biological roles and therapeutic potential. By characterizing this protein through methods such as X-ray crystallography and NMR spectroscopy, scientists aim to identify small molecules or peptides that could modulate its activity, offering new avenues for drug discovery. Overall, the exploration of ATF7IP2 as a recombinant protein is a promising frontier in molecular biology, with implications for understanding disease mechanisms and developing targeted therapies.
